nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

15.01.2018 | Review

Organic acidurias in adults: late complications and management

verfasst von: Ali Tunç Tuncel, Nikolas Boy, Marina A. Morath, Friederike Hörster, Ulrike Mütze, Stefan Kölker

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Organic acidurias (synonym, organic acid disorders, OADs) are a heterogenous group of inherited metabolic diseases delineated with the implementation of gas chromatography/mass spectrometry in metabolic laboratories starting in the 1960s and 1970s. Biochemically, OADs are characterized by accumulation of mono-, di- and/or tricarboxylic acids (“organic acids”) and corresponding coenzyme A, carnitine and/or glycine esters, some of which are considered toxic at high concentrations. Clinically, disease onset is variable, however, affected individuals may already present during the newborn period with life-threatening acute metabolic crises and acute multi-organ failure. Tandem mass spectrometry-based newborn screening programmes, in particular for isovaleric aciduria and glutaric aciduria type 1, have significantly reduced diagnostic delay. Dietary treatment with low protein intake or reduced intake of the precursor amino acid(s), carnitine supplementation, cofactor treatment (in responsive patients) and nonadsorbable antibiotics is commonly used for maintenance treatment. Emergency treatment options with high carbohydrate/glucose intake, pharmacological and extracorporeal detoxification of accumulating toxic metabolites for intensified therapy during threatening episodes exist. Diagnostic and therapeutic measures have improved survival and overall outcome in individuals with OADs. However, it has become increasingly evident that the manifestation of late disease complications cannot be reliably predicted and prevented. Conventional metabolic treatment often fails to prevent irreversible organ dysfunction with increasing age, even if patients are considered to be “metabolically stable”. This has challenged our understanding of OADs and has elicited the discussion on optimized therapy, including (early) organ transplantation, and long-term care.

Arias C, Raimann E, Peredo P et al (2014) Propionic acidemia and optic neuropathy: a report of two cases. JIMD Rep 12:1–4PubMed

Arrizza C, De Gottardi A, Foglia E, Baumgartner M, Gautschi M, Nuoffer JM (2015) Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up. Transpl Int 28:1447–1450CrossRefPubMed

Azar MR, Shakiba M, Tafreshi RI, Rashed MS (2007) Heart failure in a patient with methylmalonic acidemia. Mol Genet Metab 92:188CrossRefPubMed

Bahr O, Mader I, Zschocke J, Dichgans J, Schulz JB (2002) Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology 59:1802–1804CrossRefPubMed

Baker EH, Sloan JL, Hauser NS et al (2015) MRI characteristics of globus pallidus infarcts in isolated methylmalonic acidemia. AJNR Am J Neuroradiol 36:194–201CrossRefPubMed

Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22:867–881CrossRefPubMed

Barshes NR, Vanatta JM, Patel AJ et al (2006) Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review. Pediatr Transplant 10:773–781CrossRefPubMed

Baumgartner D, Scholl-Burgi S, Sass JO et al (2007) Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidemia. J Pediatr 150:192–197CrossRefPubMed

Baumgartner MR, Horster F, Dionisi-Vici C et al (2014) Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis 9:130CrossRefPubMedPubMedCentral

Biagosch C, Ediga RD, Hensler SV et al (2017) Elevated glutaric acid levels in Dhtkd1−/Gcdh- double knockout mice challenge our current understanding of lysine metabolism. Biochim Biophys Acta 1863:2220–2228CrossRef

Boy N, Heringer J, Haege G et al (2015) A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I. Orphanet J Rare Dis 10:163CrossRefPubMedPubMedCentral

Boy N, Heringer J, Brackmann R et al (2017a) Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity. Orphanet J Rare Dis 12:77CrossRefPubMedPubMedCentral

Boy N, Muhlhausen C, Maier EM et al (2017b) Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis 40:75–101CrossRefPubMed

Brassier A, Boyer O, Valayannopoulos V et al (2013) Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. Mol Genet Metab 110:106–110CrossRefPubMed

Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol 16:675–683PubMed

Castelnovi C, Moseley K, Yano S (2010) Maternal isovaleric acidemia: observation of distinctive changes in plasma amino acids and carnitine profiles during pregnancy. Clin Chim Acta 411:2101–2103CrossRefPubMed

Chapman KA, Summar ML, Enns GM (2012) Propionic acidemia: to liver transplant or not to liver transplant? Pediatr Transplant 16:209–210CrossRefPubMed

Charbit-Henrion F, Lacaille F, McKiernan P et al (2015) Early and late complications after liver transplantation for propionic acidemia in children: a two centers study. Am J Transplant 15:786–791CrossRefPubMed

Christensen E, Ribes A, Merinero B, Zschocke J (2004) Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:861–868CrossRefPubMed

Couce ML, Lopez-Suarez O, Boveda MD et al (2013) Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol 17:383–389CrossRefPubMed

Coude FX, Sweetman L, Nyhan WL (1979) Inhibition by propionyl-coenzyme a of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 64:1544–1551CrossRefPubMedPubMedCentral

Coude FX, Ogier H, Grimber G et al (1982) Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia. Pediatrics 69:115–117PubMed

Crombez EA, Cederbaum SD, Spector E et al (2008) Maternal glutaric acidemia, type I identified by newborn screening. Mol Genet Metab 94:132–134CrossRefPubMedPubMedCentral

de Rivero Vaccari JP, Patel HH, Brand FJ III, Perez-Pinzon MA, Bramlett HM, Raval AP (2016) Estrogen receptor beta signaling alters cellular inflammasomes activity after global cerebral ischemia in reproductively senescence female rats. J Neurochem 136:492–496CrossRefPubMed

Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112CrossRefPubMed

Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B (2006) ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29:383–389CrossRefPubMed

du Moulin M, Thies B, Blohm M, et al (2017) Glutaric aciduria type 1 and acute renal failure: case report and suggested pathomechanisms. JIMD Rep. https://doi.org/10.1007/8904_2017_44

Ensenauer R, Vockley J, Willard JM et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136–1142CrossRefPubMedPubMedCentral

Fagiuoli S, Daina E, D’Antiga L, Colledan M, Remuzzi G (2013) Monogenic diseases that can be cured by liver transplantation. J Hepatol 59:595–612CrossRefPubMed

Feinstein JA, O’Brien K (2003) Acute metabolic decompensation in an adult patient with isovaleric acidemia. South Med J 96:500–503CrossRefPubMed

Fenton WA, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York

Fowler B, Leonard JV, Baumgartner MR (2008) Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis 31:350–360CrossRefPubMed

Fragaki K, Cano A, Benoist JF et al (2011) Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia. Mitochondrion 11:533–536CrossRefPubMed

Fraidakis MJ, Liadinioti C, Stefanis L et al (2015) Rare late-onset presentation of glutaric aciduria type I in a 16-year-old woman with a novel GCDH mutation. JIMD Rep 18:85–92CrossRefPubMed

Fraser JL, Venditti CP (2016) Methylmalonic and propionic acidemias: clinical management update. Curr Opin Pediatr 28:682–693CrossRefPubMedPubMedCentral

Garcia P, Martins E, Diogo L et al (2008) Outcome of three cases of untreated maternal glutaric aciduria type I. Eur J Pediatr 167:569–573CrossRefPubMed

Gitiaux C, Roze E, Kinugawa K et al (2008) Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 23:2392–2397CrossRefPubMed

Grunert SC, Wendel U, Lindner M et al (2012) Clinical and neurocognitive outcome in symptomatic isovaleric acidemia. Orphanet J Rare Dis 7:9CrossRefPubMedPubMedCentral

Grunert SC, Bodi I, Odening KE (2017) Possible mechanisms for sensorineural hearing loss and deafness in patients with propionic acidemia. Orphanet J Rare Dis 12:30CrossRefPubMedPubMedCentral

Haarmann A, Mayr M, Kolker S et al (2013) Renal involvement in a patient with cobalamin a type (cblA) methylmalonic aciduria: a 42-year follow-up. Mol Genet Metab 110:472–476CrossRefPubMed

Habets DD, Schaper NC, Rogozinski H et al (2012) Biochemical monitoring and management during pregnancy in patients with isovaleric acidaemia is helpful to prevent metabolic decompensation. JIMD Rep 3:83–89CrossRefPubMed

Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782CrossRefPubMed

Harting I, Boy N, Heringer J et al (2015) (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites. J Inherit Metab Dis 38:829–838CrossRefPubMed

Heringer J, Boy SP, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752CrossRefPubMed

Heringer J, Valayannopoulos V, Lund AM et al (2016) Impact of age at onset and newborn screening on outcome in organic acidurias. J Inherit Metab Dis 39:341–353CrossRefPubMed

Herskovitz M, Goldsher D, Sela BA, Mandel H (2013) Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I. Neurology 81:849–850CrossRefPubMed

Horster F, Baumgartner MR, Viardot C et al (2007) Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 62:225–230CrossRefPubMed

Horster F, Garbade SF, Zwickler T et al (2009) Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630–639CrossRefPubMed

Horster F, Kolker S, Loeber JG, Cornel MC, Hoffmann GF, Burgard P (2017) Newborn screening programmes in Europe, arguments and efforts regarding harmonisation: focus on organic Acidurias. JIMD Rep 32:105–115CrossRefPubMed

Ianchulev T, Kolin T, Moseley K, Sadun A (2003) Optic nerve atrophy in propionic acidemia. Ophthalmology 110:1850–1854CrossRefPubMed

Jacquemyn Y, Den Hartog M, Eyskens F (2014) Methylmalonic acidaemia in pregnancy. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-203723

Jameson E, Walter J (2008) Cardiac arrest secondary to long QT(C )in a child with propionic acidemia. Pediatr Cardiol 29:969–970CrossRefPubMed

Kahler SG, Sherwood WG, Woolf D et al (1994) Pancreatitis in patients with organic acidemias. J Pediatr 124:239–243CrossRefPubMed

Kakavand B, Schroeder VA, Di Sessa TG (2006) Coincidence of long QT syndrome and propionic acidemia. Pediatr Cardiol 27:160–161CrossRefPubMed

Kasahara M, Sakamoto S, Kanazawa H et al (2012) Living-donor liver transplantation for propionic acidemia. Pediatr Transplant 16:230–234CrossRefPubMed

Kimmoun A, Abboud G, Strazeck J, Merten M, Gueant JL, Feillet F (2008) Acute decompensation of isovaleric acidemia induced by Graves’ disease. Intensive Care Med 34:2315–2316CrossRefPubMed

Kolker S, Pawlak V, Ahlemeyer B et al (2002) NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci 16:21–28CrossRefPubMed

Kolker S, Garbade SF, Greenberg CR et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRefPubMed

Kolker S, Garbade SF, Boy N et al (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363CrossRefPubMed

Kolker S, Garcia-Cazorla A, Valayannopoulos V et al (2015a) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 38:1041–1057CrossRefPubMed

Kolker S, Valayannopoulos V, Burlina AB et al (2015b) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis 38:1059–1074CrossRefPubMed

Korman SH, Jakobs C, Darmin PS et al (2007) Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Paediatr Neurol 11:81–89CrossRefPubMed

Kulkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142–2144CrossRefPubMed

Lam C, Desviat LR, Perez-Cerda C, Ugarte M, Barshop BA, Cederbaum S (2011) 45-year-old female with propionic acidemia, renal failure, and premature ovarian failure; late complications of propionic acidemia? Mol Genet Metab 103:338–340CrossRefPubMed

Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Muhlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J Biol Chem 286:17777–17784CrossRefPubMedPubMedCentral

Langendonk JG, Roos JC, Angus L et al (2012) A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis 35:419–424CrossRefPubMed

Lee CS, Chien YH, Peng SF et al (2013) Promising outcomes in glutaric aciduria type I patients detected by newborn screening. Metab Brain Dis 28:61–67CrossRefPubMed

Leonard JV, Walter JH, McKiernan PJ (2001) The management of organic acidaemias: the role of transplantation. J Inherit Metab Dis 24:309–311CrossRefPubMed

Lewey J, Haythe J (2014) Cardiomyopathy in pregnancy. Semin Perinatol 38:309–317CrossRefPubMed

Loeber JG, Burgard P, Cornel MC et al (2012) Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J Inherit Metab Dis 35:603–611CrossRefPubMed

Mardach R, Verity MA, Cederbaum SD (2005) Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy. Mol Genet Metab 85:286–290CrossRefPubMed

Marquard J, El Scheich T, Klee D et al (2011) Chronic pancreatitis in branched-chain organic acidurias--a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr 170:241–245CrossRefPubMed

Martinez Alvarez L, Jameson E, Parry NR, Lloyd C, Ashworth JL (2016) Optic neuropathy in methylmalonic acidemia and propionic acidemia. Br J Ophthalmol 100:98–104CrossRefPubMed

Martin-Hernandez E, Lee PJ, Micciche A, Grunewald S, Lachmann RH (2009) Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis 32:523–533CrossRefPubMed

McClelland VM, Bakalinova DB, Hendriksz C, Singh RP (2009) Glutaric aciduria type 1 presenting with epilepsy. Dev Med Child Neurol 51:235–239CrossRefPubMed

Melo DR, Kowaltowski AJ, Wajner M, Castilho RF (2011) Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr 43:39–46CrossRefPubMed

Moammar H, Cheriyan G, Mathew R, Al-Sannaa N (2010) Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008. Ann Saudi Med 30:271–277CrossRefPubMedPubMedCentral

Moorthie S, Cameron L, Sagoo GS, Bonham JR, Burton H (2014) Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis 37:889–898CrossRefPubMed

Morath MA, Okun JG, Muller IB et al (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach. J Inherit Metab Dis 31:35–43CrossRefPubMed

Morath MA, Horster F, Sauer SW (2013) Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist. Pediatr Nephrol 28:227–235CrossRefPubMed

Morris AA, Hoffmann GF, Naughten ER, Monavari AA, Collins JE, Leonard JV (1999) Glutaric aciduria and suspected child abuse. Arch Dis Child 80:404–405CrossRefPubMedPubMedCentral

Muhlhausen C, Ott N, Chalajour F et al (2006) Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res 59:196–202CrossRefPubMed

Mutze U, Roth A, Weigel JF et al (2011) Transition of young adults with phenylketonuria from pediatric to adult care. J Inherit Metab Dis 34:701–709CrossRefPubMed

Mutze U, Thiele AG, Baerwald C, Ceglarek U, Kiess W, Beblo S (2016) Ten years of specialized adult care for phenylketonuria - a single-centre experience. Orphanet J Rare Dis 11:27CrossRefPubMedPubMedCentral

Nagao M, Tanaka T, Morii M, Wakai S, Horikawa R, Kasahara M (2013) Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation. Mol Genet Metab 108:25–29CrossRefPubMed

Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT (2004) Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis 27:917–920CrossRefPubMed

Niemi AK, Kim IK, Krueger CE et al (2015) Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantation. J Pediatr 166(1455–1461):e1451

Nizon M, Ottolenghi C, Valayannopoulos V et al (2013) Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias. Orphanet J Rare Dis 8:148CrossRefPubMedPubMedCentral

Okun JG, Horster F, Farkas LM et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680CrossRefPubMed

Pena L, Franks J, Chapman KA et al (2012) Natural history of propionic acidemia. Mol Genet Metab 105:5–9CrossRefPubMed

Pierson TM, Nezhad M, Tremblay MA et al (2015) Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules. Neurogenetics 16:325–328CrossRefPubMed

Pinar-Sueiro S, Martinez-Fernandez R, Lage-Medina S, Aldamiz-Echevarria L, Vecino E (2010) Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis 33(Suppl 3):S199–S203CrossRefPubMed

Pinto A, Daly A, Evans S et al (2017) Dietary practices in isovaleric acidemia: a European survey. Mol Genet Metab Rep 12:16–22CrossRefPubMedPubMedCentral

Pitchumoni CS, Arguello P, Agarwal N, Yoo J (1996) Acute pancreatitis in chronic renal failure. Am J Gastroenterol 91:2477–2482PubMed

Pode-Shakked B, Marek-Yagel D, Rubinshtein M et al (2014) Glutaric Aciduria type I and acute renal failure - coincidence or causality? Mol Genet Metab Rep 1:170–175CrossRefPubMedPubMedCentral

Poge AP, Autschbach F, Korall H, Trefz FK, Mayatepek E (1997) Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life. Acta Paediatr 86:1144–1147CrossRefPubMed

Prada CE, Al Jasmi F, Kirk EP et al (2011) Cardiac disease in methylmalonic acidemia. J Pediatr 159:862–864CrossRefPubMed

Radmanesh A, Zaman T, Ghanaati H, Molaei S, Robertson RL, Zamani AA (2008) Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature. Pediatr Radiol 38:1054–1061CrossRefPubMed

Raval DB, Merideth M, Sloan JL et al (2015) Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review. J Inherit Metab Dis 38:839–846CrossRefPubMedPubMedCentral

Ravn K, Chloupkova M, Christensen E et al (2000) High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase. Am J Hum Genet 67:203–206CrossRefPubMedPubMedCentral

Rela M, Battula N, Madanur M et al (2007) Auxiliary liver transplantation for propionic acidemia: a 10-year follow-up. Am J Transplant 7:2200–2203CrossRefPubMed

Rodriguez-Gonzalez M, Castellano-Martinez A (2016) Long QTc syndrome and Propionic Acidemia. Indian Pediatr 53:841PubMed

Romano S, Valayannopoulos V, Touati G et al (2010) Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 156:128–134CrossRefPubMed

Ruppert T, Schumann A, Grone HJ et al (2015) Molecular and biochemical alterations in tubular epithelial cells of patients with isolated methylmalonic aciduria. Hum Mol Genet 24:7049–7059PubMed

Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme a dehydrogenase deficiency: a role for glutaryl-coenzyme a. J Biol Chem 280:21830–21836CrossRefPubMed

Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899–910CrossRefPubMed

Sauer SW, Okun JG, Hoffmann GF, Koelker S, Morath MA (2008) Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 1777:1276–1282CrossRefPubMed

Schlenzig JS, Poggi-Travert F, Laurent J et al (1995) Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis 18:448–461CrossRefPubMed

Schmitt CP, Mehls O, Trefz FK, Horster F, Weber TL, Kolker S (2004) Reversible end-stage renal disease in an adolescent patient with methylmalonic aciduria. Pediatr Nephrol 19:1182–1184PubMed

Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107–112CrossRefPubMedPubMedCentral

Scott Schwoerer J, van Calcar S, Rice GM, Deline J (2016) Successful pregnancy and delivery in a woman with propionic acidemia from the Amish community. Mol Genet Metab Rep 8:4–7CrossRefPubMedPubMedCentral

Shchelochkov OA, Dickinson K, Scharschmidt BF, Lee B, Marino M, Le Mons C (2016) Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver and provider perspectives. Mol Genet Metab Rep 8:43–47CrossRefPubMedPubMedCentral

Sloan JL, Manoli I, Venditti CP (2015) Liver or combined liver-kidney transplantation for patients with isolated methylmalonic acidemia: who and when? J Pediatr 166:1346–1350CrossRefPubMed

Spinty S, Rogozinski H, Lealman GT, Wraith JE (2002) Second case of a successful pregnancy in maternal isovaleric acidaemia. J Inherit Metab Dis 25:697–698CrossRefPubMed

Stellmer F, Keyser B, Burckhardt BC et al (2007) 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. J Mol Med (Berl) 85:763–770CrossRef

Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121C:38–52CrossRefPubMed

Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme a dehydrogenase deficiency. Brain 133:76–92CrossRefPubMed

Strauss KA, Brumbaugh J, Duffy A et al (2011) Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 104:93–106CrossRefPubMed

Tanaka K, Budd MA, Efron ML, Isselbacher KJ (1966) Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci U S A 56:236–242CrossRefPubMedPubMedCentral

Thies B, Meyer-Schwesinger C, Lamp J et al (2013) Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1. Biochim Biophys Acta 1832:1463–1472CrossRefPubMed

Traber G, Baumgartner MR, Schwarz U, Pangalu A, Donath MY, Landau K (2011) Subacute bilateral visual loss in methylmalonic acidemia. J Neuroophthalmol 31:344–346CrossRefPubMed

Tuncel AT, Ruppert T, Wang BT et al (2015) Maleic acid--but not structurally related Methylmalonic acid--interrupts energy metabolism by impaired calcium homeostasis. PLoS One 10:e0128770CrossRefPubMedPubMedCentral

Ugarte M, Perez-Cerda C, Rodriguez-Pombo P et al (1999) Overview of mutations in the PCCA and PCCB genes causing propionic acidemia. Hum Mutat 14:275–282CrossRefPubMed

Van Calcar SC (2015) Nutrition management during pregnancy: maple syrup urine disease, propionic acidemia, methylmalonic acidemia and urea cycle disorders. In: Bernstein L, Rohr F, Helm J (eds) Nutrition management of inherited metabolic diseases. Springer, Cham, p 229–240

Van Calcar SC, Harding CO, Davidson SR, Barness LA, Wolff JA (1992) Case reports of successful pregnancy in women with maple syrup urine disease and propionic acidemia. Am J Med Genet 44:641–646CrossRefPubMed

Vara R, Turner C, Mundy H et al (2011) Liver transplantation for propionic acidemia in children. Liver Transpl 17:661–667CrossRefPubMed

Vernon HJ, Bagnasco S, Hamosh A, Sperati CJ (2014) Chronic kidney disease in an adult with propionic acidemia. JIMD Rep 12:5–10CrossRefPubMed

Vester ME, Bilo RA, Karst WA, Daams JG, Duijst WL, van Rijn RR (2015) Subdural hematomas: glutaric aciduria type 1 or abusive head trauma? A systematic review. Forensic Sci Med Pathol 11:405–415CrossRefPubMedPubMedCentral

Vester ME, Visser G, Wijburg FA, van Spronsen FJ, Williams M, van Rijn RR (2016) Occurrence of subdural hematomas in Dutch glutaric aciduria type 1 patients. Eur J Pediatr 175:1001–1006CrossRefPubMedPubMedCentral

Viau K, Ernst SL, Vanzo RJ, Botto LD, Pasquali M, Longo N (2012) Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab 106:430–438CrossRefPubMed

Vilarinho L, Rocha H, Sousa C et al (2010) Four years of expanded newborn screening in Portugal with tandem mass spectrometry. J Inherit Metab Dis 33(Suppl 3):S133–S138CrossRefPubMed

Vockley J, Ensenauer R (2006) Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142C:95–103CrossRefPubMedPubMedCentral

Williams ZR, Hurley PE, Altiparmak UE et al (2009) Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 147:929–933CrossRefPubMed

Witters P, Debbold E, Crivelly K et al (2016) Autism in patients with propionic acidemia. Mol Genet Metab 119:317–321CrossRefPubMed

Zielonka M, Braun K, Bengel A, Seitz A, Kolker S, Boy N (2015) Severe acute subdural hemorrhage in a patient with glutaric aciduria type I after minor head trauma: a case report. J Child Neurol 30:1065–1069CrossRefPubMed

Titel: Organic acidurias in adults: late complications and management
verfasst von: Ali Tunç Tuncel
Nikolas Boy
Marina A. Morath
Friederike Hörster
Ulrike Mütze
Stefan Kölker
Publikationsdatum: 15.01.2018
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 5/2018
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-017-0135-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations

Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult–onset type II citrullinemia

Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders

A SEPSECS mutation in a 23-year-old woman with microcephaly and progressive cerebellar ataxia

Medical and financial burden of acute intermittent porphyria